Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
research community at the IBL and fostering strategic partnerships within and beyond Leiden University. Finally, the person appointed will be involved in shaping educational innovations to train the next
-
3 Oct 2025 Job Information Organisation/Company Leiden University Research Field Communication sciences » Editing Communication sciences » Public relations Researcher Profile Recognised Researcher
-
scale P). Leiden University offers an attractive benefits package with additional holiday (8%) and end-of-year bonuses (8.3 %), training and career development. Our individual choices model gives you some
-
€ 3.059,- to € 3.881,- gross per month (pay scale P). Leiden University offers an attractive benefits package with additional holiday (8%) and end-of-year bonuses (8.3 %), training and career development
-
communication strategies. An interest in education and innovation! Currently enrolled as a student at Leiden University. Available for two days per week. The department General information about VVI: the Van
-
University offers an attractive benefits package with additional holiday (8%) and end-of-year bonuses (8.3%), training and career development and sabbatical leave. Our individual choices model gives you some
-
-of-concept development and to write several research articles that together will form the basis of a thesis to attain a PhD degree (dr.) at Leiden University. You will participate in the education and
-
for improvement and innovation to take us further. We want to devote attention to your personal development. You can count on an enjoyable job within the socially relevant world of education and research
-
possible to join our team at the Faculty of Social and Behavioral Sciences at Leiden University. What you will do Cultural Anthropology and Development Sociology (CADS) at Leiden University studies
-
, synthetic chemists team up with immunologists from the Leiden University Medical Centre and computational scientists from the TU Delft to develop the next generation of synthetic CAAR cell therapy for serious